Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis
Kirsten M. Williams, Steven Z. Pavletic, Stephanie J. Lee, Paul J. Martin, Don Farthing, Frances T. Hakim, Jeremy J. Rose, Beryl Manning‐Geist, Juan Gea‐Banacloche, Leora E. Comis, Edward W. Cowen, David G. Justus, Kristin Baird, Guang‐Shing Cheng, Daniele Avila, Seth M. Steinberg, Sandra A. Mitchell, Ronald E. Gress
Topics & Concepts
Bronchiolitis obliteransMontelukastMedicineLeukotriene receptorClinical endpointHematopoietic stem cell transplantationInternal medicineGastroenterologyBronchiolitisLung transplantationImmunologyTransplantationClinical trialAsthmaRespiratory systemHematopoietic Stem Cell TransplantationPolyomavirus and related diseasesTransplantation: Methods and Outcomes